DataString Consulting Company Logo
DataString Consulting Company Logo
Fertility Services Market
Home»Recent Reports»Fertility Services Market

Fertility Services Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1807004, Published - December 2024

Segmented in Treatment Type (IVF, Intracytoplasmic Sperm Injection, Intrauterine Insemination, Intracervical Insemination), Patient Type (Male, Female), Service Provider, Age Demographic and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Fertility Services Market Outlook

In a time where more and more people face difficulties with fertility issues Fertility Services have become a ray of hope thats within reach transformative developments in reproductive medicine are showcased through these services addressed to a widening group looking for support to begin their families. The market, for Fertility services was estimated at $51.2 billion in 2024. It is anticipated to increase to $79.0 billion by 2030 with projections indicating a growth to around $113.4 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 7.5% over the forecast period. By making procreation more accessible, to all these services represent a forward thinking change that could influence how society views infertility and lessen any stigma.


Assisted reproduction services encompass a variety of methods and steps designed to support individuals and couples in achieving pregnancy starting from fertility evaluations and discussions to sophisticated treatments such as, in vitro fertilization (IVP) and intracytoplasmic sperm injection (ICSI).


Market Size Forecast & Key Insights

2019
$51.2B2024
2029
$105B2034

Absolute Growth Opportunity = $54.3B

The Fertility Services market is projected to grow from $51.2 billion in 2024 to $105 billion in 2034. This represents a CAGR of 7.5%, reflecting rising demand across Assisted Reproductive Technology (ART) Services, Egg and Sperm Cryopreservation Services and Fertility Diagnostics Services.

The Fertility Services market is set to add $54.3 billion between 2024 and 2034, with manufacturer targeting Intracytoplasmic Sperm Injection & Intrauterine Insemination Treatment Type projected to gain a larger market share.

With Rising trend of delayed pregnancies, and Technological advancements in fertility procedures, Fertility Services market to expand 106% between 2024 and 2034.

Opportunities in the Fertility Services Market

Boost in Fertility Tech

Advancements in technology are pushing the limits of fertility treatment options forward. The development of apps for fertility tracking, mobile devices and home based diagnostic tools indicate a direction, for customized and convenient fertility care services.

IVF Tourism on the Rise and Male Infertility An Underserved Market

The trend of seeking fertility treatments across borders is gaining traction in the fertility services industry as couples are increasingly opting for cost top notch services overseas which has given rise to a profitable sector, in IVR tourism.

In the past fertility services have mostly focused on womens well being. Nonetheless several studies indicate that male related issues play a role in nearly half of all infertility cases. This presents an opportunity, for fertility services tailored to cater to mens health needs.

Growth Opportunities in North America and Asia Pacific

Asia Pacific Outlook

In contrast the market for fertility services in the Asia Pacific region is expected to experience growth at a fast pace primarily due to the increasing number of infertility cases and greater adoption of advanced fertility treatments among people in developing nations such, as India and China.

North America Outlook

In the global fertility services market scene dominated by North America factors like heightened awareness about fertility treatments and advanced technology play a role along with the well established healthcare infrastructure in the region driving this dominance forward. Public and private investment, in health and wellness here has led to market growth. These key players are engaged in competition to solidify their positions by expanding service offerings and fostering innovation. Numerous business prospects await in the market with possibilities, for progress and the potential to offer customized treatment plans based on individual requirements.

North America Outlook

In the global fertility services market scene dominated by North America factors like heightened awareness about fertility treatments and advanced technology play a role along with the well established healthcare infrastructure in the region driving this dominance forward. Public and private investment, in health and wellness here has led to market growth. These key players are engaged in competition to solidify their positions by expanding service offerings and fostering innovation. Numerous business prospects await in the market with possibilities, for progress and the potential to offer customized treatment plans based on individual requirements.

Asia Pacific Outlook

In contrast the market for fertility services in the Asia Pacific region is expected to experience growth at a fast pace primarily due to the increasing number of infertility cases and greater adoption of advanced fertility treatments among people in developing nations such, as India and China.

Growth Opportunities in North America and Asia Pacific

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Canada, United Kingdom, Australia, India are expected to grow at 4.9% to 7.2% CAGR

2

Emerging Markets : Brazil, South Africa, Malaysia are expected to grow at 8.6% to 10.3% CAGR

Market Analysis Chart

The growth of the Fertility Services market is driven by factors with increased infertility cases worldwide being a major contributor to this trend. There are reasons for this rise such as changes in lifestyle habits the delay in parenthood among individuals pollution in our environment and sedentary work practices. These factors collectively lead to a demand for fertility services. Another key driver propelling this market forward is advancements, in technology.

Recent Developments and Technological Advancement

December 2024

Egg Bank Corporation broadened its reach by establishing five fertility centers in the Asia Pacific area as a response to the increasing need, in these developing markets.

September 2024

ReproTech Ltd unveiled an AI powered technology aimed at enhancing the accuracy and effectiveness of in vitro fertilization procedures. This initiative reflects the growing emphasis, on incorporating technology into healthcare services.

June 2024

Modern Fertility teamed up with Invitro Clinic in a partnership to offer tailored fertility solutions. This move aligns with the trend in the market, towards more personalized healthcare.

The latest advancements in the field of Fertility Services showcase a trend towards utilizing cutting edge technologies in the industry. The swift advancements in Assisted Reproductive Technologies (ART) such as In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) have brought about a transformation in fertility care. These developments have expanded the options for couples facing fertility challenges by enabling them to pursue parenthood more effectively consequently leading to an increase in demand, within the market.

Impact of Industry Transitions on the Fertility Services Market

As a core segment of the Life Science Technology industry, the Fertility Services market develops in line with broader industry shifts. Over recent years, transitions such as Upsurge in Assisted Reproductive Technology adoption and Shift towards Personalized Patient Experience have redefined priorities across the Life Science Technology sector, influencing how the Fertility Services market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Upsurge in Assisted Reproductive Technology adoption:

As infertility rates increase worldwide many people and couples are looking for help with their fertility paths. Theres a trend towards using Assisted Reproductive Technology (ART) which includes procedures like In Vitro Fertilization (IVF) Intracytoplasmic Sperm Injection (ICSI) and Egg/Sperm Donation. This shift is mainly influenced by advances, in technology growing approval and improved availability of these treatments.

2

Shift towards Personalized Patient Experience:

In todays Fertility Services market there is a trend towards offering personalized experiences, for each patient.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Life Science Technology industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Life Science Technology industry cascade into the Fertility Services market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Rising trend of Delayed Pregnancies, and Increasing Prevalence of Infertility

The average age of first time mothers is also on the rise as more women prioritize advancing their careers before starting a family. This shift towards delayed pregnancies is also playing a role in boosting the fertility services sector since fertility tends to decline with age. Consequently there has also been a surge in demand for fertility procedures, like IVF, surrogacy and egg freezing driving the growth of the market.
The direction of the fertility services market is also predominantly influenced by the increasing rates of infertility.
The rise of cutting edge technologies in fertility solutions such as time lapse imaging of embryos and pre genetic testing before implantation is also driving the growth of the fertility services industry forward. The ongoing enhancements in technologies have also boosted the effectiveness of fertility treatments leading to a surge, in numbers and thereby fuel market expansion.

Restraint: High Cost of Treatment

: The high cost of fertility services can act as a major restraint in this market. Fertility treatments like In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and other assisted reproductive technologies are often expensive, making them inaccessible to a large section of the population. The cost factor becomes even more critical in developing countries where out-of-pocket health expenditure is high and insurance coverage for such services is very limited.

Challenge: Social Stigma and Cultural Barriers

: Another significant restraint is the social stigma and cultural barriers associated with infertility.

Supply Chain Landscape

Diagnostic Services and Initial Assessment

Labcorp Inc.

OPKO Health Inc

Fertility Drugs Production

Merck & Co. Inc.

Ferring Pharmaceuticals

Assisted Reproductive Technologies (ART) Equipment Manufacturing
The Cooper Companies Inc. / Cook Medical LLC
Fertility Clinics and Hospitals
Virtus Health / The US Fertility Network
Diagnostic Services and Initial Assessment

Labcorp Inc.

OPKO Health Inc

Fertility Drugs Production

Merck & Co. Inc.

Ferring Pharmaceuticals

Assisted Reproductive Technologies (ART) Equipment Manufacturing

The Cooper Companies Inc.

Cook Medical LLC

Fertility Clinics and Hospitals

Virtus Health

The US Fertility Network

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading ProvidersProvider Strategies
Assisted Reproductive Technology (ART)
Healthcare
IVF Worldwide, Bloom IVF Centre
Implementation of advanced techniques, client education and counselling, customized treatment plans
Male Infertility Treatment
Healthcare
The Male Fertility & Sexual Medicine Specialists, Advanced Fertility Center
Offering diverse treatments, continuous research for improvement, personalized treatment approach
In Vitro Fertilization (IVF) Services
Healthcare
Boston IVF, The Lister Fertility Clinic
Incorporation of cutting-edge technology, comprehensive care and support, individualized treatment strategies
Egg and Sperm Bank Services
Healthcare
Cryo-Save AG, California Cryobank
Maintaining high-quality standards, extensive genetic testing, ethical procedures and making the process accessible to all.

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Fertility Services market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Fertility Services in Egg and Sperm Cryopreservation Services, Fertility Diagnostics Services and Assisted Reproductive Technology (ART) Services

Egg and Sperm Cryopreservation Services

Freezing and storing eggs and sperm for fertility treatments is a common practice, in the field of assisted reproduction as well.

Fertility Diagnostics Services

Another important aspect of this field is the use of fertility testing services to help individuals or couples determine the underlying reasons for their fertility challenges. You can find a range of testing and assessment methods, in these services. The key benefit is the ability to pinpoint and tackle fertility issues. This increases the likelihood of treatment. Quest Diagnostics and Progenesis are leading providers offering fertility diagnostic services.

Assisted Reproductive Technology (ART) Services

ART is widely known as one of the applications in Fertility Services and includes procedures like in vitro fertilization (IVR) where eggs are fertilized outside the body and intracytoplasmic sperm injection (ICSI) that involves injecting a single sperm into an egg to overcome various infertility challenges faced by many couples and providing them with hope for starting a family. Supporters of these techniques include known names, like Reproductive Medicine Associates and Boston IVR.

Fertility Services vs. Substitutes:
Performance and Positioning Analysis

Specialized fertility services provide tailored care for health concerns and stand out in the market due, to their focused strategies. Perhaps the biggest challenge they encounter is competing against healthcare services and natural remedies for infertility. Nevertheless the level of precision they offer and their promising growth prospects remain unparalleled in the industry.

Fertility Services
  • Surrogacy /
  • Natural remedies and lifestyle changes
    High success rates, Availability of options like IVF, ICI and IUI
    High treatment costs, Not successful for everyone
    High success rates, Wide range of options
    Costly, Risk of multiple pregnancies

Fertility Services vs. Substitutes:
Performance and Positioning Analysis

Fertility Services

  • High success rates, Availability of options like IVF, ICI and IUI
  • High treatment costs, Not successful for everyone

Surrogacy / Natural remedies and lifestyle changes

  • High success rates, Wide range of options
  • Costly, Risk of multiple pregnancies

Specialized fertility services provide tailored care for health concerns and stand out in the market due, to their focused strategies. Perhaps the biggest challenge they encounter is competing against healthcare services and natural remedies for infertility. Nevertheless the level of precision they offer and their promising growth prospects remain unparalleled in the industry.

Loading...

Research Methodology

This market research methodology defines the Fertility Services market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Life Science Technology ecosystem, we analyze Fertility Services across IVF, Intracytoplasmic Sperm Injection, and Intrauterine Insemination Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Virtus Health, Monash IVF Group, and Care Fertility Group by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Diagnostic Services and Initial Assessment, Fertility Drugs Production, and Assisted Reproductive Technologies (ART) Equipment Manufacturing. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Life Science Technology revenues to estimate the Fertility Services segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Diagnostic Services and Initial Assessment (Labcorp Inc., OPKO Health Inc), Fertility Drugs Production (Merck & Co. Inc., Ferring Pharmaceuticals), and Assisted Reproductive Technologies (ART) Equipment Manufacturing. Our parallel substitute analysis examines Surrogacy and Natural remedies and lifestyle changes, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Virtus Health, Monash IVF Group, and Care Fertility Group, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Fertility Services market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Fertility Services Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 55.0 billion
Revenue Forecast in 2034USD 105 billion
Growth RateCAGR of 7.5% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 202451.2 billion
Growth OpportunityUSD 54.3 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 202451.2 billion USD
Market Size 202763.6 billion USD
Market Size 202973.4 billion USD
Market Size 203079.0 billion USD
Market Size 2034105 billion USD
Market Size 2035113 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredTreatment Type, Patient Type, Service Provider, Age Demographic
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledVirtus Health, Monash IVF Group, Care Fertility Group, Medfem Fertility Clinic, Carolinas Fertility Institute, The London Women's Clinic, Victoria Fertility Centre, New Hope Fertility Center, IVF Worldwide, Fertility Center of San Antonio, Reproductive Medicine Associates of New Jersey and Boston IVF
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Fertility Services Market Size, Opportunities & Strategic Insights, by Treatment Type

4.1IVF
4.2Intracytoplasmic Sperm Injection
4.3Intrauterine Insemination
4.4Intracervical Insemination
Chapter 5

Fertility Services Market Size, Opportunities & Strategic Insights, by Patient Type

5.1Male
5.2Female
Chapter 6

Fertility Services Market Size, Opportunities & Strategic Insights, by Service Provider

6.1Hospitals
6.2Fertility Clinics
Chapter 7

Fertility Services Market Size, Opportunities & Strategic Insights, by Age Demographic

7.1Below 30
7.230-40
7.3Above 40
Chapter 8

Fertility Services Market, by Region

8.1North America Fertility Services Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Fertility Services Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Fertility Services Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Fertility Services Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Fertility Services Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Fertility Services Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1Virtus Health
9.2.2Monash IVF Group
9.2.3Care Fertility Group
9.2.4Medfem Fertility Clinic
9.2.5Carolinas Fertility Institute
9.2.6The London Women's Clinic
9.2.7Victoria Fertility Centre
9.2.8New Hope Fertility Center
9.2.9IVF Worldwide
9.2.10Fertility Center of San Antonio
9.2.11Reproductive Medicine Associates of New Jersey
9.2.12Boston IVF